Risks of basal cell and squamous cell carcinoma in psoriasis patients after treatment with biologic vs nonâ€biologic systemic therapies
JEADV, 2021.
Mason KJ, Burden AD, Barker J, Lunt M, Ali H, Kleyn CE, McElhone K, Soliman MM, Green AC, Griffiths CEM, Reynolds NJ, Ormerod AD
Read publication: JEADV 2021
Related
Effectiveness and persistence of acitretin, ciclosporin, fumaric acid esters and methotrexate for pa...
Associations between psoriatic arthritis and mental health among patients with psoriasis: A replicat...
The British Association of Dermatologists Biologics and Immunomodulators Register: a centenary celeb...
0 Comments